Abstract
The effect of chronic administration of salmon calcitonin (SCT) to rats with adjuvant arthritis was studied. Compared to arthritic controls, 10 units/kg day in a divided dose of SCT given s.c. resulted in a significant inhibition of paw edema and a reduction in the marked deterioration of the bones of the hind limbs, particularly those of the tarsus, as visualized by x-ray. In addition, a pronounced increase in bone density in the proximal metaphyseal area of the tibia was consistently observed in calcitonin treated animals. Animals treated with SCT also showed improved clinical symptoms including increased mobility and decreased sensitivity to handling compared to arthritic controls.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
